Aptevo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Aptevo Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aptevo Therapeutics Inc
Rating: 0.74408325
Author: Trendlyne DVM scores

about

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which target...

1.16 -0.04 (-3.33%)

99.61% Fall from 52W High

1.2M

XNAS Volume

High vol.+loss this week

XNAS 11 Dec, 2025 3:40 PM (EST)

Not Eligible

Expensive Valuation

9.3 / 100

Technically Bearish

20.4 / 100

No estimates available

Aptevo Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aptevo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which target...

99.61% Fall from 52W High

High vol.+loss this week

SWOT Analysis

Aptevo Therapeutics Inc Live Price Chart